Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamiya Mehla

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Biochemistry|February 12, 2014
Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancerJaime L Stark, Kamiya Mehla, Nina Chaika, et al.
Cancer & Metabolism|September 18, 2014
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexiaSurendra K Shukla, Teklab Gebregiworgis, Vinee Purohit, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2019
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic CancerKruti S Soni, Divya Thomas, Thomas Caffrey, et al.
Cellular and Molecular Life Sciences : CMLS|June 22, 2026
Interaction between CD82 and integrin αVβ3 selectively regulates collective movement of tumor cells via endolysosomal traffickingXue Jun Wang, Mekel M Richardson, Yingjun Ding, et al.
Cancer Letters|April 29, 2020
Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexiaSurendra K Shukla, Spas D Markov, Kuldeep S Attri, et al.
Plos One|March 14, 2012
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinomaNina V Chaika, Fang Yu, Vinee Purohit, et al.
Oncotarget|October 30, 2015
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growthSurendra K Shukla, Aneesha Dasgupta, Kamiya Mehla, et al.
Oncogene|March 29, 2019
Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinomaStaci L Haney, Michelle L Varney, Yashpal S Chhonker, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumorsKamiya Mehla, Jarrod Tremayne, James A Grunkemeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2024
The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodelingDivya Murthy, Kuldeep S Attri, Voddu Suresh, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Biochemistry|February 12, 2014
Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancerJaime L Stark, Kamiya Mehla, Nina Chaika, et al.
Cancer & Metabolism|September 18, 2014
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexiaSurendra K Shukla, Teklab Gebregiworgis, Vinee Purohit, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2019
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic CancerKruti S Soni, Divya Thomas, Thomas Caffrey, et al.
Cellular and Molecular Life Sciences : CMLS|June 22, 2026
Interaction between CD82 and integrin αVβ3 selectively regulates collective movement of tumor cells via endolysosomal traffickingXue Jun Wang, Mekel M Richardson, Yingjun Ding, et al.
Cancer Letters|April 29, 2020
Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexiaSurendra K Shukla, Spas D Markov, Kuldeep S Attri, et al.
Plos One|March 14, 2012
Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinomaNina V Chaika, Fang Yu, Vinee Purohit, et al.
Oncotarget|October 30, 2015
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growthSurendra K Shukla, Aneesha Dasgupta, Kamiya Mehla, et al.
Oncogene|March 29, 2019
Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinomaStaci L Haney, Michelle L Varney, Yashpal S Chhonker, et al.
Cancer Immunology, Immunotherapy : CII|December 6, 2017
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumorsKamiya Mehla, Jarrod Tremayne, James A Grunkemeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2024
The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodelingDivya Murthy, Kuldeep S Attri, Voddu Suresh, et al.
Pageof 5